Form 4: Definitive Healthcare CEO Kevin Coop Disposes of Shares for Tax Obligations

Definitive Healthcare Corp.'s CEO and Director, Kevin Coop, disposed of 116,750 shares of Class A Common Stock on July 1, 2025, to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Kevin Coop, Chief Executive Officer and Director of Definitive Healthcare Corp. (DH), reported a transaction on July 1, 2025.
• The transaction involved the disposition of 116,750 shares of Class A Common Stock.
• The shares were disposed of at a price of $4.05 per share.
• This disposition was a withholding by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.
• Following this transaction, Kevin Coop beneficially owns 3,622,381 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine tax withholding, indicating the vesting of equity awards, which is generally a positive sign of executive compensation structure and retention. It is not a discretionary sale by the executive.

Positives

• The transaction represents the vesting and settlement of previously granted restricted stock units, indicating the executive's continued equity alignment with the company.
• The disposition is a non-discretionary event, specifically for tax withholding, rather than a market sale by the executive.

Negatives

• The disposition of 116,750 shares reduces the direct beneficial ownership of Class A Common Stock by the CEO, although it is for a specific tax purpose.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is a report of a past insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader industry context or trends. It pertains specifically to the equity compensation of a key executive at Definitive Healthcare Corp.

Stakeholder Impact

• Shareholders: The transaction is a standard part of executive equity compensation and tax compliance, indicating the vesting of previously granted awards. It does not represent a discretionary sale that would typically signal a change in management's confidence.

Key Dates

Recommendation

Keywords

Definitive Healthcare, DH, Kevin Coop, Form 4, SEC filing, insider transaction, stock disposition, restricted stock units, tax withholding, executive compensation